GLRB

GLRB encodes the β-subunit of the heteropentameric inhibitory glycine receptor, where it contributes directly to agonist binding and channel gating rather than serving a purely structural role (PMID:11929858, PMID:23238346). Mutational electrophysiology established that distinct β-subunit residues control specific steps of receptor function: G229D and the extracellular-domain M177R reduce glycine sensitivity and maximal currents, the pore-lining 9' position L285R destabilizes the closed state to produce spontaneously active leak channels, and W310C disrupts hydrophobic packing between the M1, M2, and M3 transmembrane helices to reduce maximal currents without altering glycine sensitivity (PMID:11929858, PMID:23238346). Loss-of-function GLRB mutations — nonsense, frameshift, deletion, and splice variants — abolish β-subunit surface expression and cause hyperekplexia, defining GLRB as a major hyperekplexia gene (PMID:23184146). Beyond its synaptic role, non-coding GLRB variants modulate gene expression in brain tissue and are associated with elevated acoustic startle and fear-network activation, and partial Glrb knockout produces anxiety-related behavior in mice (PMID:28167838). The murine spastic allele illustrates a splicing-level disease mechanism in which exon 6 skipping requires cooperative inactivation of an exonic splicing enhancer together with a LINE1 retrotransposon insertion in the adjacent intron (PMID:22782896).

1. 1998 Medium

   Established the genomic architecture of GLRB, defining it as a nine-exon gene homologous to GLRA1 and revealing alternative 5'-UTR transcript usage, which framed how its expression and splicing could be regulated.

   Evidence Genomic organization analysis, in situ hybridization, and cDNA library screening

   PMID:9676428

   Open questions at the time

   • Does not address protein function or assembly
   • Functional significance of the β-B 5'-UTR variant not resolved
2. 2002 Medium

   Resolved whether the β-subunit is merely structural by showing the G229D mutation reduces agonist sensitivity, establishing a direct functional contribution of β to receptor activation.

   Evidence Electrophysiology of recombinant α1β(G229D) GlyRs measuring agonist-mediated activation

   PMID:11929858

   Open questions at the time

   • Single mutation, single lab
   • Does not map which domain mediates the ligand-binding contribution
3. 2012 High

   Defined the molecular pathology of multiple β-subunit point mutations, assigning specific residues to extracellular agonist binding (M177R), closed-state stability at the pore 9' position (L285R), and transmembrane helix packing (W310C).

   Evidence Whole-cell patch-clamp of recombinant α1β mutant GlyRs with structural modelling

   PMID:23238346

   Open questions at the time

   • Mechanistic interpretations rest partly on modelling, not experimental structure
   • Effects characterized in recombinant rather than native synaptic receptors
4. 2012 High

   Established GLRB as the third major hyperekplexia gene by linking null mutations to loss of β-subunit surface expression, connecting genotype to a defect in receptor trafficking/assembly.

   Evidence Cell-surface biotinylation, splicing assays, deletion mapping, and expression studies in a patient cohort

   PMID:23184146

   Open questions at the time

   • Mechanism of surface-expression loss (assembly vs trafficking) not fully dissected
   • Single lab cohort
5. 2012 High

   Dissected the splicing mechanism of the murine spastic allele, showing exon 6 skipping requires cooperative loss of an exonic splicing enhancer plus a LINE1 intronic insertion, illustrating how retrotransposon-driven mis-splicing reduces functional β-subunit.

   Evidence Minigene splicing assays with mutational reconstitution of the ESE and LINE1 elements

   PMID:22782896

   Open questions at the time

   • A mouse-allele mechanism; relevance to human splice variants not established here
   • Identity of the trans-acting splicing factors not defined
6. 2017 Medium

   Extended GLRB function beyond hyperekplexia by showing non-coding variants modulate brain GLRB expression and associate with startle and fear-network activation, with partial knockout mice displaying anxiety-related behavior.

   Evidence GWAS, expression analysis in brain tissue and cell culture, and behavioral assays in partial Glrb knockout mice

   PMID:28167838

   Open questions at the time

   • GWAS association not mechanistically definitive alone
   • Circuit linking reduced GLRB to anxiety not resolved
7. 2020 Medium

   Distinguished the in vivo behavioral consequences of β-subunit versus α1-subunit loss, showing heterozygous spastic (Glrb) mice lack a startle phenotype whereas spasmodic (Glra1) mice show enhanced startle and fear changes.

   Evidence Startle and fear-conditioning behavioral phenotyping of Glrb spastic and Glra1 spasmodic mouse mutants

   PMID:32848605

   Open questions at the time

   • Only heterozygous Glrb tested in this comparison
   • Does not resolve the molecular basis of the differing behavioral outcomes

• How GLRB β-subunit dosage and synaptic GlyR composition translate into specific affective and startle circuit outputs remains unresolved.
• No experimental structure of the human β-containing receptor in the corpus
• Trans-acting regulators of GLRB splicing/expression unidentified
• Circuit-level link between GLRB expression and anxiety behavior not mechanistically mapped